Clinical Trial Update: Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial update evaluating inhaled nitric oxide as an anti-inflammatory and anti-reperfusion therapy in infants and children undergoing ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Congenital Heart Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-11-04